p4 amboss Flashcards
classic presentation of BPD?
Persistent tachypnea
Labored breathing (intercostal and subcostal retractions)
FiO2 > 30% to maintain peripheral saturation > 90%
Diffuse granular densities with basal atelectasis on x-ray
Later in the disease course, interspersed cystic areas and diffuse hyperinflation of the lung can develop
Chronic cough not responsive to antihistamine?
GERD likely? Antacid
GERD unlikely: PFT–NC–BPCT
Acide base disorder in OSA?
Near normal PH Compensated respiratory acidosis Low serum chloride hypoxia (normal non apneic episode) Chronic Co2 retention
treatment for sever sulpha allergy patient with PCP?
IV clindamycin and oral primaquine
OHS diagnosis?
in patients with BMI ≥ 30 kg/m2 with symptoms similar to OSA (excessive daytime sleepiness, restless sleep, snoring with apneic episodes) and evidence of daytime alveolar hypoventilation on arterial blood gas (ABG) analysis that cannot be otherwise explained.
APA sx?
In patients with bronchial asthma, there should be concern for ABPA if respiratory symptoms worsen despite treatment and features of bronchiectasis (e.g., productive cough with thick brown sputum, thickened airways with irregular cystic opacities on chest x-ray) develop along with an elevated ESR, eosinophilia, and very high concentrations of serum IgE.
management?
prednisolone
itraconazole
treatment of OSA?
Treat all patients with diagnosed OSA.
First-line treatment: positive airway pressure (PAP)
Consider alternative treatment in patients who are unable to tolerate or decline PAP:
Oral appliances
Positional therapy
Upper airway modifications
Supportive care should include management of risk factors, e.g., weight loss and sleep hygiene.
Nocturnal positive pressure t
Upper airway modifications?
Description: surgical dilatation of the upper airway or neurostimulation of upper airway muscles
Procedures
Uvulopalatopharyngoplasty: resection of the uvula and redundant retrolingual, soft palate, and tonsillar tissue
Other procedures include hypoglossal nerve stimulation, radiofrequency ablation of tongue and/or soft palate tissue, and palatal implants. [33][38][39]
two key epidemiological groups(risk factor) in which sarcoidosis is common?
gender, and race, of African descent and women ages 25–35 and 45–65 years
ankylosisng spondilitis PFT?
Normal compliance
low FVC1/FVC
Normal/increase ratio of Fvc1/FVC
Normal residual volume
confirmatory test for bronchiectasis?
A high-resolution CT scan of the chest is the
Findings?
include dilated bronchi with thickened walls and a possible signet ring appearance, tram track lines (i.e., parallel linear opacities caused by thickened walls of dilated bronchi), lower lobe cysts, and honeycombing.
Management of Myasthenia gravis?
Early endotracheal intubation
IVIg
Plasmapheresis
differentiation of MGC from cholinergic crisis?
criteria.1st MGC/2nd CC Pupil Normal Miosis Fasciculations None Present Heart rate Tachycardia Bradycardia Skin Cold and faint Warm and flushed Bronchial secretion Normal Increased
complication?
Infection: otitis media Respiratory Bordetella pertussis pneumonia Hemoptysis, atelectasis, pneumothorax Neurologic: seizures, encephalopathy with possible permanent damage
MCC of pan cost tumor?
(usually a type of NSCLC such as bronchogenic adenocarcinoma)
treatment of choice for legionellosis?
Fluoroquinolones (e.g., levofloxacin) are the treatment of choice for legionellosis
apnea of prematurity cause?
Immature respiratory control
preterm and LBW is the risk
CM?
in first 2-3 day
episodes of breathing pauses (usually > 20 seconds) that are frequently accompanied by hypoxemia and/or bradycardia
is clinical diagnosis
management?
Supportive care (e.g., supplemental oxygen, neutral thermal environment, maintaining a physiological neck position, avoidance of excessive nasal suctioning) Nasal CPAP Methylxanthine therapy (e.g., caffeine, theophylline)
diagnosis?
clinical
intermidiate risk solitary lung nodule?
S;0.8-2 cm A:40-60 scaloped border UL lesion current smoking
next step to do?
PET
Positron emission tomography (PET) function and indication?
Can determine if the nodule is metabolically active and should be Considered for the evaluation of low-risk or intermediate-risk nodules, which are ≥ 8 mm.
FDG-avid nodules should undergo biopsy for histopathological examination. FDG-nonavid nodules should be monitored with a follow-up CT scan.
Alternatively, patients with intermediate- or high-risk nodules can proceed directly to biopsy.
Direct surgical biopsy for ?
Is typically reserved for large lesions (> 30 mm) or smaller lesions with concerning features based on other modalities that assess risk.
Do tracheobronchial
the most appropriate diagnostic step for a case of recurrent pneumonia in the same anatomic region.
A CT scan of the chest